Sunshine Biopharma Inc (SBFM)

[DDMasterStocks]

$SBFM BIG covid-19 play FDA APPROVAL & PATENTS PENDING COVID-19!

Sunshine Biopharma (SBFM) board link:

https://investorshub.advfn.com/Sunshine-Biopharma-Inc-SBFM-14329/


Daily Chart: http://schrts.co/yQktcZah

Weekly Chart: http://schrts.co/NEDhmJPt

News: https://www.otcmarkets.com/stock/SBFM/news

Business Summary: Sunshine Biopharma Inc. id pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of aggressive form of cancer and covid-19 with patents (adva-27a & covid-19 through covid-30).

Sunshine Biopharma Inc is incorporated in Colorado State and has a formation date of 08/31/2006

Company Website: https://www.sunshinebiopharma.com/

FDA, Amazon, Amazon Chocie & Health Canada confirmation links

https://www.accessdata.fda.gov/scripts/SDA/sdDetailNavigation.cfm?sd=srolist&id=AAFBD03FC656992DE053554DA8C01706&rownum=2

Amazon Choice:

https://www.amazon.ca/Sunshine-Biopharma-WHEY-Protein-Powder/dp/B07RYZHN81/ref=sr_1_2?keywords=Sunshine+Biopharma&qid=1589323043&sr=8-2


Amazon:

https://www.amazon.ca/s?k=Sunshine+Biopharma&ref=bl_dp_s_web_0

Health Canada:

Natural Product Number (NPN): 80089663
Current status: Active
Brand name(s): Essential 9
Licence holder: Sunshine Biopharma Inc.
Dosage Form: Tablet
Recommended route of administration Oral

Link: https://health-products.canada.ca/lnhpd-bdpsnh/info.do?licence=80089663

Natural Product Number (NPN): 80093432
Current status: Active
Brand name(s): Essential Calcium Vitamin D
Licence holder: Sunshine Biopharma Inc.
Dosage Form: Tablet
Recommended route of administration: Oral

Link: https://health-products.canada.ca/lnhpd-bdpsnh/info.do?licence=80093432

Patent: 10,272,065
Reassignment Date: 2019-02-27
Current Assignee: Sunshine Biopharma Inc
Owner name: SUNSHINE BIOPHARMA INC., CANADA
Effective Date: 20190226
Status: Active
Anticipated Expiration: 2034-01-13


Patent: 8,236,935
Reassignment Date: 2019-02-27
Current Assignee: Sunshine Biopharma Inc
Owner name: SUNSHINE BIOPHARMA INC., CANADA
Effective date: 20190226
Status: Active
Anticipated Expiration: 2028-11-07

https://www.otcmarkets.com/stock/SBFM/disclosure
https://sec.report/Ticker/SBFM
https://www.nasdaq.com/market-activity/stocks/sbfm/sec-filings

The dates line up with the filings. That was a summarization of what was filed.

Recent filings
Sunshine Biopharma, Inc's CFO/Secretary just picked up 2,626,327 shares - July 15, 2020

Sunshine Biopharma, Inc's Chief Operating Officer just picked up 2,400,000 shares - July 13, 2020

Sunshine Biopharma, Inc's Chief Executive Officer just picked up 2,723,673 shares - July 10, 2020

Sunshine Biopharma, Inc's Chief Executive Officer just picked up 500,000 shares - June 25, 2020

Sunshine Biopharma Files A Patent Application For A New CORONAVIRUS COVID-19 TREATMENT - June 3, 2020